StockData
Artiva Biotherapeutics, Inc. logo

Artiva Biotherapeutics, Inc. (ARTV) stock

ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.86−0.10 (-2.53%)

Close on Nov 17, 2026Market cap $188.72MP/E –Yield –

Artiva Biotherapeutics total assets

Total assets on the balance sheet at the end of each period.

Artiva Biotherapeutics's total assets was $368.63M at Jun 30, 2026. For fiscal 2025 it was $130.94M, down 37.5% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$130.94M-37.5%
FY2024Dec 31, 2024$209.58M+99.4%
FY2023Dec 31, 2023$105.11M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$368.63M+117.6%
Q1 FY2026Mar 31, 2026$105.96M-44.6%
Q4 FY2025Dec 31, 2025$130.94M-37.5%
Q3 FY2025Sep 30, 2025$148.86M-34.0%
Q2 FY2025Jun 30, 2025$169.39M+123.1%
Q1 FY2025Mar 31, 2025$191.26M+82.0%
Q4 FY2024Dec 31, 2024$209.58M–
Q3 FY2024Sep 30, 2024$225.60M–
Q2 FY2024Jun 30, 2024$75.91M–
Q4 FY2023Dec 31, 2023$105.11M–

More Artiva Biotherapeutics figures

See a number that looks wrong?